Price
$5.86
Decreased by -3.14%
Dollar volume (20D)
13.58 M
ADR%
7.70
Earnings report date
Mar 12, 2025
Shares float
59.43 M
Shares short
5.39 M [9.06%]
Shares outstanding
84.94 M
Market cap
513.88 M
Beta
-0.33
Price/earnings
N/A
20D range
5.46 7.46
50D range
5.46 7.87
200D range
4.32 11.40

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity.

The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow.

It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity.

The company was incorporated in 2016 and is headquartered in Foster City, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Nov 12, 24 -0.28
Increased by +33.33%
-0.32
Increased by +12.50%
Aug 5, 24 -0.31
Decreased by -24.00%
-0.34
Increased by +8.82%
May 13, 24 -0.30
Increased by +3.23%
-0.34
Increased by +11.76%
Mar 14, 24 -0.29
Increased by 0.00%
-0.29
Nov 14, 23 -0.42
Increased by +4.55%
-0.31
Decreased by -35.48%
Aug 8, 23 -0.25
Increased by +54.55%
-0.34
Increased by +26.47%
May 15, 23 -0.31
Increased by +43.64%
-0.27
Decreased by -14.81%
Mar 27, 23 -0.29
Increased by +48.21%
-0.43
Increased by +32.56%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 24 N/A
Decreased by N/A%
-21.95 M
Increased by +26.28%
- -
Jun 30, 24 0.00
Decreased by N/A%
-22.74 M
Decreased by -27.05%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-22.37 M
Decreased by -3.93%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 1.32 M
Increased by +N/A%
-21.02 M
Decreased by -32.85%
Decreased by -1.59 K%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-29.77 M
Decreased by -76.97%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-17.90 M
Decreased by -28.47%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-21.53 M
Decreased by -56.31%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Decreased by -100.00%
-15.82 M
Decreased by -11.05%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY